Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPP635 450 mg Once Daily in Mild to Moderate Hypertension
2006-004176-13Phase 2Completed
- Sponsor
- Speedel
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypertension (HTN) comparing SPP635 with Placebo (2 arms). Primary endpoint: Change in blood pressure from baseline after 4 weeks of treatment. Started Jan 2007; status: completed.
02
Drugs
SPP 635
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2006-004176-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004176-13.